Jääskeläinen T - Search Results

1

Genetic Risk Factors and Gene-Lifestyle Interactions in Gestational Diabetes.

Jääskeläinen T, Klemetti MM. Jääskeläinen T, et al. Nutrients. 2022 Nov 13;14(22):4799. doi: 10.3390/nu14224799. Nutrients. 2022. PMID: 36432486 Free PMC article. Review.

2

New insights into the genetic basis of premature ovarian insufficiency: Novel causative variants and candidate genes revealed by genomic sequencing.

Jaillard S, Bell K, Akloul L, Walton K, McElreavy K, Stocker WA, Beaumont M, Harrisson C, Jääskeläinen T, Palvimo JJ, Robevska G, Launay E, Satié AP, Listyasari N, Bendavid C, Sreenivasan R, Duros S, van den Bergen J, Henry C, Domin-Bernhard M, Cornevin L, Dejucq-Rainsford N, Belaud-Rotureau MA, Odent S, Ayers KL, Ravel C, Tucker EJ, Sinclair AH. Jaillard S, et al. Among authors: jaaskelainen t. Maturitas. 2020 Nov;141:9-19. doi: 10.1016/j.maturitas.2020.06.004. Epub 2020 Jun 20. Maturitas. 2020. PMID: 33036707 Free article.

3

Synthetic 20-epi analogs of calcitriol are potent inducers of target-gene activation in osteoblastic cells.

Ryhänen S, Mahonen A, Jääskeläinen T, Mäenpää PH. Ryhänen S, et al. Among authors: jaaskelainen t. Eur J Biochem. 1996 May 15;238(1):97-103. doi: 10.1111/j.1432-1033.1996.0097q.x. Eur J Biochem. 1996. PMID: 8665957 Free article.

4

Inhibition of proliferation and induction of differentiation of osteoblastic cells by a novel 1,25-dihydroxyvitamin D3 analog with an extensively modified side chain (CB1093).

Ryhänen S, Jääskeläinen T, Saarela JT, Mäenpää PH. Ryhänen S, et al. Among authors: jaaskelainen t. J Cell Biochem. 1998 Sep 1;70(3):414-24. doi: 10.1002/(sici)1097-4644(19980901)70:3<414::aid-jcb14>3.0.co;2-k. J Cell Biochem. 1998. PMID: 9706878

5

Retinoid-X-receptor-alpha-independent binding of vitamin D receptor to its response element from human osteocalcin gene.

Jääskeläinen T, Itkonen A, Mäenpää PH. Jääskeläinen T, et al. Eur J Biochem. 1995 Mar 1;228(2):222-8. Eur J Biochem. 1995. PMID: 7705332 Free article.

6

Solar urticaria: demonstration of histamine release and effective treatment with doxepin.

Neittaanmäki H, Jääskeläinen T, Harvima RJ, Fräki JE. Neittaanmäki H, et al. Among authors: jaaskelainen t. Photodermatol. 1989 Feb;6(1):52-5. Photodermatol. 1989. PMID: 2471960 No abstract available.

7

Characterization of human 1,25-dihydroxyvitamin D3 receptor anti-peptide antibodies.

Tuohimaa P, Bläuer M, Jääskeläinen T, Itkonen A, Lindfors M, Mahonen A, Palvimo J, Vilja P, Mäenpää PH. Tuohimaa P, et al. Among authors: jaaskelainen t. J Steroid Biochem Mol Biol. 1992 Dec;43(7):649-57. doi: 10.1016/0960-0760(92)90290-y. J Steroid Biochem Mol Biol. 1992. PMID: 1472457

8

A novel vitamin D analog with two double bonds in its side chain. A potent inducer of osteoblastic cell differentiation.

Mahonen A, Jääskeläinen T, Mäenpää PH. Mahonen A, et al. Among authors: jaaskelainen t. Biochem Pharmacol. 1996 Apr 12;51(7):887-92. doi: 10.1016/0006-2952(95)02242-2. Biochem Pharmacol. 1996. PMID: 8651937

9

Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein.

Ryhänen S, Jääskeläinen T, Mahonen A, Mäenpää PH. Ryhänen S, et al. Among authors: jaaskelainen t. Biochem Pharmacol. 2003 Aug 1;66(3):495-504. doi: 10.1016/s0006-2952(03)00283-1. Biochem Pharmacol. 2003. PMID: 12907249

10

State of methylation of the human osteocalcin gene in bone-derived and other types of cells.

Ryhänen S, Pirskanen A, Jääskeläinen T, Mäenpää PH. Ryhänen S, et al. Among authors: jaaskelainen t. J Cell Biochem. 1997 Sep 1;66(3):404-12. doi: 10.1002/(sici)1097-4644(19970901)66:3<404::aid-jcb12>3.0.co;2-e. J Cell Biochem. 1997. PMID: 9257196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page